Adam Craig | President, Chief Executive Officer and Interim Chief Medical Officer |
James Fong | Executive Vice President and Chief Commercial Officer |
David Kirske | Executive Vice President and Chief Financial Officer |
Kelly Shi | Jefferies |
Kenneth Shields | SVB Securities |
Bert Hazlett | BTIG |
Benjamin Burnett | Stifel |
Reni Benjamin | JMP Securities |
Gil Blum | Needham & Company |
Thomas Flaten | Lake Street Capital Markets |
Good afternoon. Thank you for standing by. Welcome to CTI BioPharma Third Quarter 2022 Earnings Call.
During today's presentation, all parties will be in listen-only mode. This conference is being recorded today, November 7, 2022.